Status:
NOT_YET_RECRUITING
Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.
Lead Sponsor:
Olivier F. Bertrand
Conditions:
Coronary Arterial Disease (CAD)
Restenosis, Coronary
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events ...
Eligibility Criteria
Inclusion
- Adults (\>=18 years of age)
- Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
- Identified in the institutional procedure database
Exclusion
- Incomplete or non-available data on the post-procedural clinical follow-up
- Procedures where other devices were used in combination with drug-eluting balloons.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2036
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06972225
Start Date
May 1 2025
End Date
March 1 2036
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUCPQ
Québec, Quebec, Canada, G1V4G5